The Acute, Synergistic Effects of Protein and Calcium on Appetite and Energy Intake
- Conditions
- Healthy
- Interventions
- Dietary Supplement: Porridge-based breakfast.Dietary Supplement: ProteinDietary Supplement: Calcium
- Registration Number
- NCT01986036
- Lead Sponsor
- Northumbria University
- Brief Summary
High-protein meals have previously been shown to acutely reduce appetite and energy intake. More recently, meals higher in calcium have also been shown to increase feelings of fullness, circulating insulin and intestinal peptide concentrations and reduce appetite sensations.
This study aims to assess whether calcium and protein act synergistically to acutely influence appetite and energy intake.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- Male or Female
- BMI 18.5-29.9 kg/m2
- Age: 18-40 years
- Smokers
- Food allergies
- Metabolic disorders (ie. type 2 diabetes)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description CONTROL Porridge-based breakfast. Control breakfast low in protein and calcium. Porridge-based breakfast. PROTEIN Protein High-protein breakfast. PROTEIN Porridge-based breakfast. High-protein breakfast. CALCIUM Calcium High-calcium breakfast. CALCIUM Porridge-based breakfast. High-calcium breakfast. PRO-CAL Protein High-protein and calcium breakfast. PRO-CAL Calcium High-protein and calcium breakfast. PRO-CAL Porridge-based breakfast. High-protein and calcium breakfast.
- Primary Outcome Measures
Name Time Method Energy Intake 60 min post test-meal Energy intake will be assessed by ad libitum consumption of a homogenous pasta meal, 1 h after the test-meal.
- Secondary Outcome Measures
Name Time Method Subjective appetite sensations 1 hr Subjective appetite sensations (hunger, satisfaction, prospective consumption and fullness) will be assessed by visual analogue scales at baseline, and every 15 min following test-meal consumption.
Insulin concentrations 1 hr Plasma insulin concentrations will be determined at baseline and every 15 min following test-meal consumption.
GLP-1 (7-36) concentrations 1 hr Plasma glucagon-like peptide-1 (GLP-1) (7-36) concentrations will be determined at baseline and every 15 min following consumption of the test meal.
GIP concentration 1 hr Plasma glucose-dependent insulinotropic peptide (GIP) concentrations will be determined at baseline and evert 15 min following test-meal consumption.
Trial Locations
- Locations (1)
Northumbria University
🇬🇧Newcastle upon Tyne, Tyne and Wear, United Kingdom